Bmpr2b2b2556Clo
Chemically induced Allele Detail
|
Symbol: |
Bmpr2b2b2556Clo |
Name: |
bone morphogenetic protein receptor type 2; Bench to Bassinet Program (B2B/CVDC) mutation 2556, Cecilia Lo |
MGI ID: |
MGI:5560496 |
Gene: |
Bmpr2 Location: Chr1:59802721-59917240 bp, + strand Genetic Position: Chr1, 30.44 cM, cytoband C2
|
Alliance: |
Bmpr2b2b2556Clo page
|
|
Mutant 2556-004-1 (E16.5) exhibits parallel outflow tracts and ventricles appear thin which is diagnosed as PTA (Type A4) and ventricular non-copmaction by EFIC imaging and the heart is malrotated further to the left
Show the 9 phenotype image(s) involving this allele.
|
|
|
Strain of Origin: |
C57BL/6J
|
Project Collection: |
B2B/CvDC
|
|
Allele Type: |
|
Chemically induced (ENU) |
Mutation: |
|
Single point mutation
|
|
|
Mutation details: This ENU-induced mutation was isolated in a screen at the University of Pittsburgh. The molecular lesion is a T to C substitution at nucleotide +2 after coding nucleotide 852 (c.852+2T>C, NM_007561) in intron 6, changing splice donor site T-GT to T-GC (which is assumed to be less efficient).
(J:175213)
Additional
incidental mutations
were detected in sequencing for the causative mutation,
Bmpr2b2b2556Clo, and may be present in stocks carrying this mutation.
|
|
|
Key: |
hm |
homozygous |
ht |
heterozygous |
tg |
involves transgenes |
√ |
phenotype observed |
cn |
conditional genotype |
cx |
complex: > 1 genome feature |
ot |
other: hemizygous, indeterminate,... |
N |
normal phenotype |
|
Genotype/ Background: |
| Allelic Composition | Genetic Background | Cell Line(s) |
---|
Loading... | | | | |
|
Phenotypes: |
Affected Systems |
|
|
cardiovascular system
|
√
|
abnormal myocardium compact layer morphology
|
√
|
persistent truncus arteriosus type i
|
√
|
persistent truncus arteriosus type iv
|
√
|
atrioventricular septal defect
|
√
|
muscular ventricular septal defect
|
√
|
abnormal semilunar valve morphology
|
√
|
muscle
|
√
|
abnormal myocardium compact layer morphology
|
√
|
renal/urinary system
|
√
|
hydronephrosis
|
√
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 0 strains available
Cell Lines: 0 lines available
|
Carrying any Bmpr2 Mutation: |
46 strains or lines available
|
|
Summative Diagnosis:
Cardiovascular Phenotype: Persistent truncus arteriosus (PTA, Typa 1 and Type A4), atrioventricular septal defect (AVSD), muscular ventricular septal defect (VSD), ventricular non-compaction, absent semilunar valves
Noncardiovascular Phenotype: Hydronephrosis
Fyler Codes
The Fyler code developed by The Boston Children's Heart Foundation in Boston Children's Hospital provides a hierarchical clinical diagnosis of congenital cardiovascular defects and other disorders. These codes are used to delineate pathology in the mutant mouse models that parallel human disease and can be cross referenced to the International Pediatric and Congenital Cardiac Code (IPCCC) ( http://www.ipccc.net/).
Fyler Code ID |
Code Description |
0500 |
Truncus arteriosus |
1100 |
Atrioventricular canal (endocardial cushion defect) |
1802 |
Excessive myocardial trabeculation or noncompaction |
4502 |
Hydronephrosis |
4906 |
Non-cardiac abnormality |
|
Original: |
J:175213 Lo C, Information submitted by the NHLBI Cardiovascular Development Consortium (CvDC), Bench to Bassinet Program (B2B/CvDC). MGI Direct Data Submission (B2B/CvDC). 2011-09-12; |
All: |
2 reference(s) |
|